Aligos Therapeutics, Inc.

NasdaqCM:ALGS 주식 보고서

시가총액: US$58.9m

Aligos Therapeutics 배당금

배당금 기준 확인 0/6

Aligos Therapeutics does not have a record of paying a dividend.

주요 정보

n/a

배당 수익률

-30.3%

환매 수익률

총 주주 수익률-30.3%
미래 배당 수익률n/a
배당금 성장n/a
다음 배당금 지급일n/a
전 배당일n/a
주당 배당금n/a
지급 비율n/a

최근 배당금 업데이트

업데이트 없음

Recent updates

Aligos Therapeutics, Inc. (NASDAQ:ALGS) Stock Catapults 49% Though Its Price And Business Still Lag The Industry

Jul 31
Aligos Therapeutics, Inc. (NASDAQ:ALGS) Stock Catapults 49% Though Its Price And Business Still Lag The Industry

Aligos Therapeutics (NASDAQ:ALGS) Will Have To Spend Its Cash Wisely

Jul 16
Aligos Therapeutics (NASDAQ:ALGS) Will Have To Spend Its Cash Wisely

Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) 27% Dip In Price Shows Sentiment Is Matching Revenues

May 24
Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) 27% Dip In Price Shows Sentiment Is Matching Revenues

Aligos Therapeutics, Inc. (NASDAQ:ALGS) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Apr 09
Aligos Therapeutics, Inc. (NASDAQ:ALGS) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) Share Price Is Matching Sentiment Around Its Revenues

Feb 23
Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) Share Price Is Matching Sentiment Around Its Revenues

Here's Why We're Watching Aligos Therapeutics' (NASDAQ:ALGS) Cash Burn Situation

Oct 24
Here's Why We're Watching Aligos Therapeutics' (NASDAQ:ALGS) Cash Burn Situation

We Think Aligos Therapeutics (NASDAQ:ALGS) Needs To Drive Business Growth Carefully

Jul 17
We Think Aligos Therapeutics (NASDAQ:ALGS) Needs To Drive Business Growth Carefully

We Think Aligos Therapeutics (NASDAQ:ALGS) Needs To Drive Business Growth Carefully

Mar 11
We Think Aligos Therapeutics (NASDAQ:ALGS) Needs To Drive Business Growth Carefully

Aligos Therapeutics begins 12-week dosing in phase 1b study to treat hepatitis B

Jul 25

We're Keeping An Eye On Aligos Therapeutics' (NASDAQ:ALGS) Cash Burn Rate

Jul 11
We're Keeping An Eye On Aligos Therapeutics' (NASDAQ:ALGS) Cash Burn Rate

We're Keeping An Eye On Aligos Therapeutics' (NASDAQ:ALGS) Cash Burn Rate

Feb 02
We're Keeping An Eye On Aligos Therapeutics' (NASDAQ:ALGS) Cash Burn Rate

Here's Why We're Not Too Worried About Aligos Therapeutics' (NASDAQ:ALGS) Cash Burn Situation

Oct 19
Here's Why We're Not Too Worried About Aligos Therapeutics' (NASDAQ:ALGS) Cash Burn Situation

Aligos Therapeutics EPS beats by $0.16

May 10

We're Hopeful That Aligos Therapeutics (NASDAQ:ALGS) Will Use Its Cash Wisely

May 01
We're Hopeful That Aligos Therapeutics (NASDAQ:ALGS) Will Use Its Cash Wisely

What Is The Ownership Structure Like For Aligos Therapeutics, Inc. (NASDAQ:ALGS)?

Jan 16
What Is The Ownership Structure Like For Aligos Therapeutics, Inc. (NASDAQ:ALGS)?

Dosing underway for Aligos Therapeutics' hepatitis B candidate in early-stage study

Oct 30

결제의 안정성과 성장

배당금 데이터 가져오기

안정적인 배당: Insufficient data to determine if ALGS's dividends per share have been stable in the past.

배당금 증가: Insufficient data to determine if ALGS's dividend payments have been increasing.


시장 대비 배당 수익률

Aligos Therapeutics 시장 대비 배당 수익률
ALGS 배당 수익률은 시장과 어떻게 비교되나요?
세그먼트배당 수익률
회사 (ALGS)n/a
시장 하위 25% (US)1.5%
시장 상위 25% (US)4.5%
업계 평균 (Biotechs)2.2%
애널리스트 예측 (ALGS) (최대 3년)n/a

주목할만한 배당금: Unable to evaluate ALGS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

고배당: Unable to evaluate ALGS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


주주에 대한 수익 배당금

수익 보장: Insufficient data to calculate ALGS's payout ratio to determine if its dividend payments are covered by earnings.


주주에 대한 현금 배당금

현금 흐름 범위: Unable to calculate sustainability of dividends as ALGS has not reported any payouts.


강력한 배당금 지급 기업 알아보기